Mathieu Puyade

10PUBLICATIONS
25CO-AUTHORS
Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.

Tobias Alexander, Elisa Roldan, Nicoletta Del Papa

|May 31, 2023
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.

Cyrille Coustal, Juliette Vanoverschelde, Xavier Quantin

|Oct 27, 2022
Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database.

Mickaël Martin, Hoan-My Nguyen, Clément Beuvon

|Feb 25, 2022
Safety of Immune Checkpoint Inhibitor Resumption after Interruption for Immune-Related Adverse Events, a Narrative Review.

Marion Allouchery, Clément Beuvon, Marie-Christine Pérault-Pochat

|Apr 09, 2021
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory study.

Matthias Papo, Chloé Friedrich, Laure Delaval

|Jan 11, 2021
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer.

Marion Allouchery, Thomas Lombard, Mickael Martin

Pageof 2

Frequent Collaborators

2 joint publications

Zora Marjanovic

1 joint publications

Hubert de Boysson

1 joint publications

Thomas Sené

1 joint publications

Pascale Palassin